Literature DB >> 24485680

Effects of folic acid and vitamin B12 supplementation on culling rate, diseases, and reproduction in commercial dairy herds.

M Duplessis1, C L Girard2, D E Santschi3, J-P Laforest4, J Durocher3, D Pellerin4.   

Abstract

This study was undertaken to determine the effect of a combined folic acid and vitamin B12 supplement given in early lactation on culling rate, metabolic disorders and other diseases, and reproduction in commercial dairy herds. A total of 805 cows (271 primiparous and 534 multiparous cows) in 15 commercial dairy herds were involved. Every 2mo from February to December 2010 and within each herd, cows were assigned according to parity, previous 305-d milk production, and calving interval to 5mL of either (1) saline 0.9% NaCl (control group) or (2) 320mg of folic acid + 10mg of vitamin B12 (vitamin group). Treatments were administered weekly by intramuscular injections starting 3wk before the expected calving date until 8wk after parturition. A total of 221 cows were culled before the next dry period. Culling rate was not affected by treatment and was 27.5%; culling rate was greater for multiparous (32.2%) than for primiparous cows (18.8%). Within the first 60d in milk (DIM), 47 cows were culled, representing 21.3% of total culling, and no treatment effect was noted. Ketosis incidence based on a threshold ≥100µmol/L of β-hydroxybutyrate in milk was 38.3±2.9% for the vitamin group and 41.8±3.0% for the control group and was not affected by treatment. The combined supplement of folic acid and vitamin B12 did not decrease incidence of retained placenta, displaced abomasum, milk fever, metritis, or mastitis. However, the incidence of dystocia decreased by 50% in multiparous cows receiving the vitamin supplement, although no effect was observed in primiparous cows. The first breeding postpartum for multiparous cows occurred 3.8d earlier with the vitamin supplement compared with controls, whereas no treatment effect was seen for primiparous cows. Days open, first- and second-breeding conception rates, number of breedings per conception, and percentage of cows pregnant at 150 DIM were not affected by treatment. The reduced percentage of dystocia combined with the earlier DIM at first breeding for multiparous cows receiving the combined supplementation in folic acid and vitamin B12 indicates that the vitamin supplement had a positive effect in older cows.
Copyright © 2014 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  commercial herds; dairy cow; folic acid; vitamin B(12)

Mesh:

Substances:

Year:  2014        PMID: 24485680     DOI: 10.3168/jds.2013-7369

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  4 in total

1.  Folic acid and flaxseed oil supplements in Ossimi ewes: effect on body weight changes, progesterone profile, blood chemistry, and litter traits.

Authors:  Mahmoud S El-Tarabany; Mostafa A Atta; Sana S Emara; Mohamed M Mostafa
Journal:  Trop Anim Health Prod       Date:  2019-07-23       Impact factor: 1.559

2.  Consequences of supplying methyl donors during pregnancy on the methylome of the offspring from lactating and non-lactating dairy cattle.

Authors:  Alex Bach; Anna Aris; Isabel Guasch
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

3.  Genetic Basis of Blood-Based Traits and Their Relationship With Performance and Environment in Beef Cattle at Weaning.

Authors:  Josue Chinchilla-Vargas; Luke M Kramer; John D Tucker; Donald S Hubbell; Jeremy G Powell; Toby D Lester; Elizabeth A Backes; Karen Anschutz; Jared E Decker; Kenneth J Stalder; Max F Rothschild; James E Koltes
Journal:  Front Genet       Date:  2020-07-03       Impact factor: 4.599

4.  Effect of Folic Acid Supplements on Progesterone Profile and Blood Metabolites of Heat-Stressed Holstein Cows during the Early Stage of Pregnancy.

Authors:  Abdelrahman A Kilany; Abdel-Halim A El-Darawany; Akram A El-Tarabany; Khaled M Al-Marakby
Journal:  Animals (Basel)       Date:  2022-07-22       Impact factor: 3.231

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.